Here are relevant reports on : artificial-intelligence-global-market-research-report
-
Cell Harvesting Market by Type (Manual, Automated), Application (Biopharmaceutical, Stem Cell Research), End User (Biotechnology, Biopharmaceutical Companies, Research Institute), and Region (North America, Europe, APAC, Row) - Global Forecasts to 2023
The global cell harvesting market is expected to reach USD 324.5 Million by 2023, at a CAGR of 8.7%. Some of the major players operating in the cell harvesting market are PerkinElmer (US), Brandel (US), TOMTEC (US), Cox Scientific (UK), Connectorate (Switzerland), Scinomix (US), ADSTEC (Japan), and Terumo BCT (a part of Terumo Corporation) (Japan).
- Published: March 2018
- Price: $ 4950
- TOC Available:
-
Neuromarketing Tools, Technologies, & Services Market by Tool (Hardware Solution, Software Platform), Technology (EEG & Brainware Monitoring, Biometric & Physiological Monitoring), End Users (Clinical Research, Consumer Research) - Global Forecast to 2030
The neuromarketing tools, technologies, and services market is segmented by tools (hardware solutions like EEG amplifiers, eye-tracking, biometric devices, and software platforms), technologies (EEG & brainwave monitoring, eye-tracking, biometric & physiological monitoring), and end users (commercial & enterprise solutions, consumer research, academic & clinical research, and others). Market estimates are derived through extensive secondary and primary research, applying top-down and bottom-up approaches with data triangulation. The study covers global and regional market dynamics, competitive landscape, and forecasts up to 2030, profiling key players such as Tobii AB, iMotions, EMOTIV, Brain Products, Smart Eye, and others.
- Published: March 2026
- Price: $ 4950
- TOC Available:
-
Expression Vectors Market by Host Type (Bacterial/E.Coli, Mammalian/CHO, Insect/Baculovirus, and Yeast), Application (Therapeutic, Research, and Industrial), End User (Pharmaceutical, Biotechnology, CROs & CMOs, and Academic Research) - Forecast to 2020
The expression vectors market is expected to reach $317.1 Million by 2020 from $242.7 Million in 2015, growing at a CAGR of 5.5% from 2015 to 2020. Major factors driving the growth of this market include the increasing demand of protein-based drugs (biologics); high prevalence of lifestyle diseases, infectious diseases, and genetic disorders; and increasing funding for protein research. On the other hand, high market consolidation, which increases entry barriers, and high cost of protein therapy are the major factors restraining the growth of this market.
- Published: June 2015
- Price: $ 4950
- TOC Available:
-
Biomarkers Market by Offering (Consumables, Software, Services), Type (Safety, Efficacy), Research Area (Genomics, Proteomics), Technology (PCR, MS), Disease (Cancer, Infectious, Neurological), Application (Diagnostic, Research) - Global Forecast to 2030
The global biomarkers market, valued at US$58.07 billion in 2024, stood at US$62.39 billion in 2025 and is projected to advance at a resilient CAGR of 10.8% from 2025 to 2030, culminating in a forecasted valuation of US$104.15 billion by the end of the period. This growth is supported by the growing use of biomarkers in drug development and the increasing role of companion diagnostics in advancing precision medicine.
- Published: March 2026
- Price: $ 4950
- TOC Available:
-
Europe Biomarkers Market by Offering (Consumables, Software, Services), Type (Safety, Efficacy), Research Area (Genomics, Proteomics), Technology (PCR, MS), Disease (Cancer, Infectious), Application (Diagnostic, Research)- Forecast to 2030
The Europe biomarkers Market, valued at US$16.40 billion in 2024, stood at US$17.46 billion in 2025 and is projected to advance at a resilient CAGR of 10.0% from 2025 to 2030, culminating in a forecasted valuation of US$28.11 billion by the end of the period. A biomarker (short for biological marker) is a measurable indicator of a biological condition or process, often used to diagnose diseases, predict disease progression, and evaluate treatment response; this market includes consumables, services, and software used for biomarker-related research.
- Published: March 2026
- Price: $ 4950
- TOC Available:
-
Asia Pacific Biomarkers Market by Offering (Consumables, Software, Services), Type (Safety, Efficacy), Research Area (Genomics, Proteomics), Technology (PCR, MS), Disease (Cancer, Infectious), Application (Diagnostic, Research)- Forecast to 2030
The Asia Pacific biomarkers Market, valued at US$13.51 billion in 2024, stood at US$14.73 billion in 2025 and is projected to advance at a resilient CAGR of 12.4% from 2025 to 2030, culminating in a forecasted valuation of US$26.40 billion by the end of the period. A biomarker (short for biological marker) is a measurable indicator of a biological condition or process, often used to diagnose diseases, predict disease progression, and evaluate treatment response; this market includes consumables, services, and software used for biomarker-related research.
- Published: March 2026
- Price: $ 4950
- TOC Available:
-
Cell Sorting Market by Technology (FACS-based Droplet Sorting, MACS, Microfluidics), Product (Cell Sorters, Reagents, Consumables), Application (Research, Clinical), End User (Research Institutes, Biopharma Companies, Medical Schools) - Forecasts to 2021
The global cell sorting market is projected to grow at a CAGR of 7.0%. Factors such as technological advancements in cell sorters, rising funding and investments for development of technologically advanced cell sorters, and growing adoption of cell sorting techniques in research activities are driving the growth of this market. The market is further driven by factors such as the growing prevalence of HIV/AIDS and cancer, expanding pharmaceutical and biotechnology industries, and launch of specific reagents for specific applications. However, factors such as the high cost of instruments and lack of awareness & technical knowledge regarding the use of cell sorters are hampering the growth of this market.
- Published: January 2017
- Price: $ 4950
- TOC Available:
-
North America Biomarkers Market by Offering (Consumables, Software, Services), Type (Safety, Efficacy), Research Area (Genomics, Proteomics), Technology (PCR, MS), Disease (Cancer, Infectious), Application (Diagnostic, Research)-Forecast to 2030
The North America biomarkers Market, valued at US$23.35 billion in 2024, stood at US$25.13 billion in 2025 and is projected to advance at a resilient CAGR of 11.0% from 2025 to 2030, culminating in a forecasted valuation of US$45.25 billion by the end of the period. A biomarker (short for biological marker) is a measurable indicator of a biological condition or process, often used to diagnose diseases, predict disease progression, and evaluate treatment response.
- Published: March 2026
- Price: $ 4950
- TOC Available:
-
Artificial Intelligence (AI) Supercomputer Market Size, Share, Industry Growth, Trends & Analysis by Components (Processors/Compute, Storage, Memory, Interconnects), Deployment (Cloud, On-Premises), Application (Government, Academia and Research, Commercial) and Geography – Global Forecast to 2028
The AI supercomputer market is expected to grow from USD 1.2 billion in 2023 to USD 3.3 billion by 2028, at a compound annual growth rate (CAGR) of 22.0% during the forecast period.The Key Players NIVIDIA Corporation (US), Intel Corporation (US), Advanced Micro Devices, Inc. (US), Samsung Electronics (South Korea), Micron Technology, Inc. (US), IBM Corporation (US), Meta (US) Google (US), Dell Inc. (US), Microsoft (US), Huawei Technologies Co., Ltd. (China) Cerebras (US) and Hewlett Packard Enterprise Development LP (US). Fujitsu (Japan), Pezy Group (Netherlands), Tesla (US), Atos SE (France), NEC Corporation (Japan), Oracle (US), Amazon Web Services, Inc. (US), Groq, Inc. (US), MediaTek Inc. (Taiwan), Graphcore (UK), SambaNova Systems Inc. (US), Kalray (France), Kneron Inc. (US), Arm Ltd. (UK).
- Published: October 2023
- Price: $ 4950
- TOC Available:
-
Research Antibodies & Reagents Market by Product (Antibodies (Type, Form, Source, Research Area), Reagents), Technology (Western blot, Flow Cytometry, ELISA), Application (Proteomics, Genomics), End User (Pharma, Biotech, CROs) & Region - Global forecast to 2028
The global research antibodies & reagents market, valued at US$1.3 billion in 2022, stood at US$1.8 billion in 2023 and is projected to advance at a resilient CAGR of 45.6% from 2023 to 2028, culminating in a forecasted valuation of US$12.1 billion by the end of the period. The growth of this market is largely driven by an increase in research activity—especially in the life sciences industry—along with growing industry-academia collaborations are a primary growth driver for this market.
- Published: October 2023
- Price: $ 4950
- TOC Available:
Records 41 to 50 of 50
